JAMES O'MAY: Open Payments
NPI 1902836604 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 17 payments from 9 companies in 2025. Trend: 2023 $246 · 2024 $458 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 4 | $254 |
| Novo Nordisk Inc | 3 | $66 |
| Exact Sciences Corporation | 3 | $62 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $52 |
| Solventum Corporation | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: REAL INTELLIGENCE, Cologuard Collection Kit, JOURNAVX, PREVENA, VOQUEZNA, Ozempic, Iovera, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
